Legal Opinion
Galderma Laboratories, L.P. v. Tolmar, Inc.
Court of Appeals for the Federal Circuit
Decided December 11, 2013No. 18-2013PublishedCited by 63 opinions
1Opinion of the Court
PROST, Circuit Judge.
In this patent infringement case, Tol-mar, Inc. challenges the district court’s holding that the claims of U.S. Patent Nos. 7,579,377 (’377 patent); 7,737,181 (’181 patent); 7,834,060 (’060 patent); 7,838,558 (’558 patent); and 7,868,044 (’044 patent), which are owned by Galderma Laboratories, L.P., Galderma S.A., and Galderma Research and Development, S.N.C. (collectively, “Galderma”) are not invalid under 35 U.S.C. § 103. We find that the district court erred in finding the claims of the asserted patents not invalid as obvious. Accordingly, we reverse.
I. Baciíground
This…
2Cases cited16 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Merck & Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2005
- DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc.Court of Appeals for the Federal Circuit · 2009
11 more not listed; retrieve them via the Exa API.
3Cited by63 opinions
- Arctic Cat Inc. v. Bombardier Recreational Products Inc.Court of Appeals for the Federal Circuit · 2017
- Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2014
- Allergan, Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2015
- Stryker Corporation v. Zimmer, Inc.Court of Appeals for the Federal Circuit · 2016
- E.I. Dupont De Nemours & Co. v. Synvina C.V.Court of Appeals for the Federal Circuit · 2018
58 more not listed; retrieve them via the Exa API.